Pharma channel feed

FDA halts im­ports of sev­er­al Sun Phar­ma drugs made in In­dia due to out­stand­ing qual­i­ty is­sues

3 years ago
FDA+
Manufacturing

No­var­tis' ip­ta­co­pan meets PhI­II test in fight against rare blood dis­ease

3 years ago
R&D

SABCS roundup: No­var­tis shows two-year PFS in breast can­cer sub­groups; As­traZeneca re­veals more En­her­tu da­ta

3 years ago

Big Phar­mas team up with lo­cal Sin­ga­pore or­ga­ni­za­tions to boost man­u­fac­tur­ing

3 years ago
Manufacturing

Phar­ma rep­u­ta­tion re­tains 'halo' even as pan­dem­ic me­dia cov­er­age re­cedes — sur­vey

3 years ago
Marketing

Suf­fer­ing in si­lence: COPD pa­tients face fre­quent symp­toms, dis­sat­is­fac­tion with meds, but don't talk to docs — sur­vey

3 years ago
Marketing

Flori­da judge dis­miss­es Zan­tac can­cer claims against GSK, oth­er phar­mas

3 years ago
Law

Ei­sai re-ups metasta­t­ic breast can­cer aware­ness cam­paign with strik­ing pa­tient pho­tographs

3 years ago
Marketing

Glen­mark hit with warn­ing let­ter over pro­ce­dures, qual­i­ty con­trol is­sues at In­dia man­u­fac­tur­ing plant

3 years ago
FDA+
Manufacturing

Klick Health an­nu­al hol­i­day spot­light se­nior lone­li­ness and the pow­er of con­nec­tion

3 years ago
Marketing

Pfiz­er and BioN­Tech look to toss Mod­er­na patent suit, call­ing claims 'unen­force­able'

3 years ago
Coronavirus
Law

Sum­i­to­vant sub­sidiaries En­zy­vant and Al­ta­vant merge in­to com­bined com­pa­ny

3 years ago
Deals
Manufacturing

Eu­ro­pean Com­mis­sion lays ground­work to un­wind Il­lu­mi­na's $7B+ Grail merg­er

3 years ago

Q&A: Bris­tol My­er­s' Kris­ten Hege on cell ther­a­py, can­cer pa­tients and men­tor­ing the next gen­er­a­tion

3 years ago
Marketing

Mar­ket­ingRx roundup: Phar­mas lay off Twit­ter ads for an­oth­er week; WPP un­cov­ers LGBTQ+ mar­ket­ing find­ings

3 years ago
Marketing

In­no­force opens new man­u­fac­tur­ing site in Chi­na

3 years ago
Manufacturing

FDA grants or­phan drug des­ig­na­tion to Al­ger­non's ifen­prodil, while ex­clu­siv­i­ty re­mains un­clear

3 years ago
FDA+

Pfiz­er makes an­oth­er bil­lion-dol­lar in­vest­ment in Eu­rope and ex­pands again in Michi­gan

3 years ago
Manufacturing

‘Catchy’ de­sign tops big ad buys on­line for grab­bing on­col­o­gists’ at­ten­tion — sur­vey

3 years ago
Marketing

No­var­tis bol­sters Plu­vic­to's case in prostate can­cer with PhI­II re­sults

3 years ago
FDA+

And then there were two: Janssen bows out of Hori­zon takeover ne­go­ti­a­tions

3 years ago
Deals

Am­gen, years be­hind ri­vals, says PhI obe­si­ty drug shows dura­bil­i­ty signs

3 years ago
R&D

Bay­er starts work on $43M+ ex­pan­sion of OTC man­u­fac­tur­ing site in Penn­syl­va­nia

3 years ago
Financing
Manufacturing

US month­ly costs for biosim­i­lars 'sub­stan­tial­ly high­er' than Ger­many or Switzer­land, JA­MA re­search finds

3 years ago
First page Previous page 157158159160161162163 Next page Last page
A service from the Financial Times